[
    [
        {
            "time": "",
            "original_text": "流感概念股盘中拉升走高 葵花药业涨停",
            "features": {
                "keywords": [
                    "流感",
                    "概念",
                    "股",
                    "拉升",
                    "走高",
                    "葵花药业",
                    "涨停"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "健康"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "流感概念股盘中拉升走高 葵花药业涨停",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 10,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "138股获券商买入评级，会畅通讯目标涨幅达93.60%",
            "features": {
                "keywords": [
                    "券商",
                    "买入",
                    "评级",
                    "会畅通讯",
                    "目标涨幅",
                    "93.60%"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "通信",
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "138股获券商买入评级，会畅通讯目标涨幅达93.60%",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 7,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "康希诺生物新冠疫苗开始国际三期临床试验 于俄罗斯批准临床入组",
            "features": {
                "keywords": [
                    "康希诺生物",
                    "新冠",
                    "疫苗",
                    "国际",
                    "三期",
                    "临床试验",
                    "俄罗斯",
                    "批准"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康希诺生物新冠疫苗开始国际三期临床试验 于俄罗斯批准临床入组",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 10,
                "Entity_Density": 9,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]